130
Views
0
CrossRef citations to date
0
Altmetric
Review

Thyroid malignant neoplasm-associated biomarkers as targets for oncolytic virotherapy

, , &
Pages 35-43 | Published online: 21 Jun 2016

References

  • DeanDSGharibHEpidemiology of thyroid nodulesBest Pract Res Clin Endocrinol Metab200822690191119041821
  • CunninghamMPDudaRBRecantWChmielJSSylvesterJAFremgenASurvival discriminants for differentiated thyroid cancerAm J Surg19901603443472221232
  • HundahlSAFlemingIDFrogmenAMMenckHRA National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S. 1985–1995Cancer19988312263826489874472
  • SaggioratoEDe PompaRVolanteMCharacterization of thyroid ‘follicular neoplasms’ in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical applicationEndocr Relat Cancer200512230531715947105
  • PersidisACancer multidrug resistanceNat Biotechnol19991794959920278
  • SethiKSarkarSDasSMohantyBMandalMBiomarkers for the diagnosis of thyroid cancerJ Exp Ther Oncol20108434135221222366
  • GloverARLeeJCSidhuSBIs there an accurate biomarker test for thyroid cancer recurrence on the horizon?Int J Endo Oncol20141135
  • MelvinKEMillerHHTashjianAHEarly diagnosis of medullary carcinoma of the thyroid gland by means of calcitonin assayN Engl J Med1971285111511205095737
  • GroganRHMitmakerEJClarkOHReview, the evolution of biomarkers in thyroid cancer-from mass screening to a personalized biosignatureCancers2010288591224281099
  • SafranMChalifa-CaspiVShmueliOHuman gene-centric databases at the Weizmann Institute of Science: GeneCards, UDB, CroW 21 and HORDENucl Aci Res2003311142146
  • BinderJXPletscher-FrankildSTsafouKCompartments: unification and visualization of protein subcellular, localization evidenceDatabase (Oxford)20142014bau01224573882
  • LoofeltHPichonCJolivetABiochemistry, two-subunit structure of the human thyrotropin receptorProc Nail Acad Sci U S A19928937653769
  • DaviesTMariansRLatifRThe TSH receptor reveals itselfClin Invest2002110161164
  • BarbosaGFMilasMPeripheral thyrotropin receptor mRNA as a novel marker for differentiated thyroid cancer diagnosis and surveillanceExpert Rev Anticancer Ther2008891415142418759693
  • MizukamiYHashimotoTNonomuraAImmunohistochemical demonstration of thyrotropin (TSH)-receptor in normal and diseased human thyroid tissues using monoclonal antibody against recombinant human TSH-receptor proteinJ Clin Endocrinol Metab19947926166198045985
  • WilliamsGRExtra thyroidal expression of TSH receptorAnn Endocrinol (Paris)2011722687321511243
  • SuAIWiltshireTBatalovSA gene atlas of the mouse and human protein-encoding transcriptomesProc Natl Acad Sci U S A2004101166062606715075390
  • TanakaKSonooHYamamotoYChanges of expression level of the differentiation markers in papillary thyroid carcinoma under thyrotropin suppression therapy in vivo immunohistochemical detection of thyroglobulin, thyroid peroxidase, and thyrotropin receptorJ Surg Oncol200075210811611064390
  • ChinnappaPTagubaLArciagaRDetection of thyrotropin-receptor messenger ribonucleic acid (mRNA) and thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease: sensitive and specific markers for thyroid cancerJ Clin Endocrinol Metab20048983705370915292293
  • WendlingPTSHR mRNA arrives as thyroid cancer markerEndocrinology20101511
  • MazzaferriELThyroid carcinoma: papillary and follicularMazzaferriLSamaanNAEndocrine TumorCambridge, MABlackwell Scientific Publications1993278333
  • SpitzwegCMorrisJCReview, sodium iodide symporter (NIS) and thyroidHormons2002112234
  • DohanODe la ViejaAParoderVThe sodium/iodide symporter (NIS): characterization, regulation, and medical significanceEndocr Rev200324487712588808
  • DohanOCarrascoNAdvances in Na+/I− symporter (NIS) research in the thyroid and beyondMol Cell Endocrinol20032131597015062574
  • Riesco-EizaguirreGSantistebanPA perspective view of sodium iodide symporter research and its clinical implicationsEur J Endocrinol2006155449551216990649
  • TazebayUHWapnirILLevyOThe mammary gland iodide transporter is expressed during lactation and in breast cancerNature Medicine200068871878
  • BiscollaRPCeruttiJMMacielRMDetection of recurrent thyroid cancer by sensitive nested reverse transcription-polymerase chain reaction of thyroglobulin and sodium/iodide symporter messenger ribonucleic acid transcripts in peripheral bloodJ Clin Endocrinol Metab200085103623362711061512
  • PatelAJhiangSDograSDifferentiated thyroid carcinoma that express sodium-iodide symporter have a lower risk of recurrence for children and adolescentsPediatr Res200252573774412409522
  • SchmutzlerCWinzerRMeissner-WeiglJKöhrleJRetinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cellsBiochem Biophys Res Commun19972408328389398654
  • SaitoTEndoTKawaguchiAIncreased expression of the sodium/iodide symporter in papillary thyroid carcinomasJ Clin Invest19981017129613009525971
  • KogaiTTakiKBrentGAEnhancement of sodium/iodide symporter expression in thyroid and breast cancerEndocrinol Relat Cancer2006133797826
  • RufJCarayonPStructural and functional aspects of thyroid peroxidaseArch Biochem Biophys2006445226927716098474
  • KimuraSHongYSKotaniTOhtakiSKikkawaFStructure of the human thyroid peroxidase gene: comparison and relationship to the human myeloperoxidase geneBiochemistry198928448144892548579
  • GardasALewartowskaASuttonBJPasiekaZMcGregorAMBangaJPHuman thyroid peroxidase (TPO) isoforms, TPO-1 and TPO-2: analysis of protein expression in Graves’ thyroid tissueJ Clin Endocrinol Metab19978211375237579360536
  • KimuraSKotaniTMcBrideOWHuman thyroid peroxidase: complete cDNA and protein sequence, chromosome mapping, and identification of two alternately spliced mRNAsProc Natl Acad Sci U S A19878416555555593475693
  • WeberKBShroyerKRHeinzDENawazSSaidMSHaugenBRThe use of a combination of galectin-3 and thyroid peroxidase for the diagnosis and prognosis of thyroid cancerAm J Clin Pathol2004122452453115487449
  • RoddigerSJBojungaJKleeVDetection of thyroid peroxidase mRNA in peripheral blood of patients with malignant and benign thyroid diseasesJ Mol Endocrinol200229328729512459031
  • IshikawaTMiwaMUchidaKQuantitation of thyroid peroxidase mRNA in peripheral blood for early detection of thyroid papillary carcinomaThyroid200616543544216756464
  • TanakaTUmekiKYamamotoISugiyamaSNoguchiSOhtakiSImmuno histochemical loss of thyroid peroxidase in papillary thyroid carcinoma: strong suppression of peroxidase gene expressionJ Pathol1996179189948691351
  • LazarVBidartJMCaillouBExpression of the Na(+)/I(−) symporter gene in human thyroid tumors: a comparison study with other thyroid- specific genesJ Clin Endocrinol Metab1999843228323410487692
  • YinAHMiragliaSZanjaniEDAC133, is a novel marker for human hematopoietic stem and progenitor cellsBlood19979012500250129389720
  • MakABPeharMNixonAMPost translational regulation of CD133 by ATase1/ATase2 -mediated lysine acetylationJ Mol Biol20144262175218224556617
  • ChenKHuangHYChenJIUnderstanding and targeting cancer stem cells: therapeutic implications and challengesActa Pharmacol Sin20133473274023685952
  • FriedmanSLuMSchultzAThomasDLinR-YCD133+ anaplastic thyroid cancer cells initiate tumors in immunodeficient mice and are regulated by thyrotropinPLoS One200944e539519404394
  • KeCCLiuRSTsaiYFTsengLMLeeOKLeeCHHigh pluripotent status and metastatic ability of CD133 positive cells in primary papillary thyroid cancerJ Nucl Med201051suppl 21128
  • LiuJBrownREImmunohistochemical detection of epithelialmesenchymal transition associated with stemness phenotype in anaplastic thyroid carcinomaInt J Clin Exp Pathol20103875576221151388
  • KeCCLiuRSYangAHCD133-expressing thyroid cancer cells are undifferentiated, radioresistant and survive radioiodide therapyEur J Nucl Med Mol Imaging2013401617123081821
  • DonnenbergVSLandreneauRJDonnenbergADTumorigenic stem and progenitor cells: implications for the therapeutic index of anti-cancer agentsJ Control Release2007122338539117582641
  • SpringFADalchauRDanielsGLThe Ina and Inb blood group antigens are located on a glycoprotein of 80,000 MW (the CDw44 glycoprotein) whose expression is influenced by the In (Lu) geneImmunology199864137432454887
  • AruffoAStamenkovicIMelnickMUnderhillCBSeedBCD44 is the principal cell surface receptor for hyaluronateCell199061130313131694723
  • FiggeJdel RosarioADGerasimovGPreferential expression of the cell adhesion molecule CD44 in papillary thyroid carcinomaExp Mol Pathol19946132032117541370
  • TakanoTSumizakiHNakanoKMatsuzukaFKumaKAminoNIncreased expression of CD44 variants in differentiated thyroid cancersJpn J Cancer Res19968712124512509045959
  • GuJDaaTKashimaKYokoyamaSNakayamaINoguchiSExpression of splice variants of CD44 in thyroid neoplasms derived from follicular cellsPathol Int19984831841909589486
  • BöhmJPNiskanenLKPirinenRTReduced CD44 standard expression is associated with tumour recurrence and unfavourable outcome in differentiated thyroid carcinomaJ Pathol2000192332132711054715
  • SamijaIMatešaNLukačJKusićZGalectin-3 and CD44v6 as markers for preoperative diagnosis of thyroid cancer by RT-PCRDiagn Mol Pathol201120423324122089351
  • SmartEJGrafGAMcNivenMACaveolins, liquid-ordered domains, and signal transductionMol Cell Biol199919117289730410523618
  • KrajewskaWMMasłowskaICaveolins: structure and function in signal transductionCell Mol Biol Lett20049219522015213803
  • OkamotoTSchlegelASchererPELisantiMPCaveolins, a family of scaffolding proteins for organizing “preassembled signaling complexes” at the plasma membraneJ Biol Chem199827310541954229488658
  • BastianiMPartonRGCaveolae at a glanceJ Cell Sci20101233831383621048159
  • PaskašSJankovićJMarečkoICaveolin-1 expression in papillary thyroid carcinoma: correlation with clinicopathological parameters and BRAF mutation statusOtolaryngol Head Neck Surg2014150220120924255086
  • ItoYYoshidaHNakanoKCaveolin-1 overexpression is an early event in the progression of papillary carcinoma of the thyroidBr J Cancer200286691291611953823
  • ItoYYoshidaHTomodaCCaveolin-1 and 14-3-3 sigma expression in follicular variant of thyroid papillary carcinomaPathol Res Pract20052018–954554916259106
  • DumicJDabelicSFlögelMGalectin-3: an open-ended storyBiochim Biophys Acta20061760461663516478649
  • LermaEGalectin-1 is overexpressed in myeloid cells and there is a significant different overexpression in cells carrying the BCR-ABLChimeric Gene Blood2005106 Abstract4383. [ASH Annual Meeting Abstracts]
  • FeilchenfeldtJTötschMSheuSYExpression of galectin-3 in normal and malignant thyroid tissue by quantitative PCR and immunohistochemistryMod Pathol200316111117112314614051
  • GoliABigottiGParentePFedericoFCastriFMassiGAtypical thyroid nodules express both HBME-1 and galectin-3, two phenotypic markers of papillary thyroid carcinomaJ Exp Clin Can Res2007262221227
  • SalehHAFengJTabassumFAl-ZohailiOHusainMGiorgadzeTDifferential expression of galectin-3, CK19, HBME1, and Ret oncoprotein in the diagnosis of thyroid neoplasms by fine needle aspiration biopsyCytojournal20091861819826479
  • SongQWangDLouYDiagnostic significance of CK19, TG, Ki67 and galectin-3 expression for papillary thyroid carcinoma in the northeastern region of ChinaDiagn Pathol2011612622188859
  • KaufmanHLKimDWDeRaffeleGMitchamJCoffinRSKim-SchulzeSLocal and distant immunity induced by intralesional vaccination with an oncolytic herpes virus encoding GM-CSF in patients with stage IIIc and IV melanomaAnn Surg Oncol201017371873019915919
  • NicklinSABakerAHTropism-modified adenoviral and adeno-associated viral vectors for gene therapyCurr Gene Ther20022327329312189716
  • GuanMXRomanoGCoronitiRHendersonEEReview, Progress in oncolytic virotherapy for the treatment of thyroid malignant neoplasmJ Exp Clin Can Res20143391111
  • CoughlanLAlbaRParkerALTropism-modification strategies for targeted gene delivery using adenoviral vectorsViruses20102102290235521994621
  • WuCMacLeodISuAIBioGPS and MyGene.info: organizing online, gene-centric informationNucl Aci Res201341Database issueD561D565
  • NicholsonLBVlaseHGravesPMonoclonal antibodies to the human TSH receptor: epitope mapping and binding to the native receptor on the basolateral plasma membrane of thyroid follicular cellsJ Mol Endocrinol19961621591709156519
  • HobbyPGardasARadomskiRMcGregorAMBangaJPSuttonBJIdentification of an immunodominant region recognized by human autoantibodies in a three dimensional model of thyroid peroxidaseEndocrinology20001412018202610830285
  • BressonDRebuffatSAPéraldi-RouxSReview, Localization of the immunodominant region on human thyroid peroxidase in autoimmune thyroid diseases: an updateJ Autoimmune Dis20052211815762980
  • ArscottPLKoenigRJKaplanMMGlickGDBakerJRJrUnique autoantibody epitopes in an immunodominant region of thyroid peroxidaseJ Biol Chem1996271496649738617771
  • HuangJRuBZhuPMimo DB 2.0: a mimotope database and beyondNucleic Acids Res2011401D271D27722053087